BRINZOLAMIDE-INDUCED EYE DISCHARGE: A RARE ENTITY
Abstract
ABSTRACT
A 62-year-old lady diagnosed to have normal tension glaucoma was receiving triple therapy of topical brinzolamide, timolol, and careprost. Post
application of brinzolamide eye drops patient experienced mucoid eye discharge starting 10 minutes after application of eye drops and persisting
for ½ hr. Slit lamp examination findings did not reveal any signs of infection. She gave a history of mucoid discharge since the day she was started on
brinzolamide eye drops. There are only two case reports describing mucoid discharge following brinzolamide eye drops. Thus, we report a similar
scenario in our patient. We report this case so as to avoid unnecessary suspicion of infection in such cases.
Keywords: Glaucoma, mucoid, infection.
Downloads
References
REFERENCES
Roy FH, Fraunfelder FW. Open-angle glaucoma. Roy and Fraunfelder’s
Current Ocular Therapy. 6
ed. Ch. 272. Philadelphia, PA: Saunders;
p. 504-8.
th
Henderer DJ, Rapuano CJ. Ocular pharmacology. Goodman & Gilman’s
The Pharmacological Basis of Therapeutics. 12
ed., Ch. 64. New York,
NY: Pergamon Press; 1991. p. 1787.
th
Inoue K, Shiokawa M, Ishida K, Tomita G. Safety and efficacy of
switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to
brinzolamide 1.0%/timolol maleate 0.5% eye drops. Clin Ophthalmol
;9:619-23.
Whitson JT, Realini T, Nguyen QH, McMenemy MG, Goode SM.
Six-month results from a Phase III randomized trial of
fixed-combination brinzolamide 1%+ brimonidine 0.2% versus
brinzolamide or brimonidine monotherapy in glaucoma or ocular
hypertension. Clin Ophthalmol (Auckland, NZ) 2013;7:1053.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.